Demirkan Arda, Orazakunov Erkin, Savaş Berna, Kuzu M Ayhan, Melli Mehmet
Ankara University, School of Medicine, Ibni Sina Hospital, Department of Emergency Medicine, Sihhiye, Ankara, Turkey.
World J Gastroenterol. 2008 Jan 21;14(3):463-8. doi: 10.3748/wjg.14.463.
To investigate whether oral glutamine pretreatment prevents impairment of intestinal mucosal integrity during ischemia-reperfusion (I/R) in rats.
The study was performed as two series with 40 rats in each. Each series of animals was divided into four groups. The first group was used as a control. Animals in the second group were only pretreated with oral glutamine, 1 g/kg for 4 d. The third group received a normal diet, and underwent intestinal I/R, while the fourth group was pretreated with oral glutamine in the same way, and underwent intestinal I/R. Intestinal mucosal permeability to (51)Cr-labeled EDTA was measured in urine in the first series of animals. In the second series, histopathological changes in intestinal tissue and plasma endotoxin levels were evaluated.
Intestinal I/R produced a significant increase in intestinal permeability, plasma endotoxin level and worsened histopathological alterations. After intestinal I/R, permeability was significantly lower in glutamine-treated rats compared to those which received a normal diet. However, no significant change was observed in plasma endotoxin levels or histopathological findings.
Although glutamine pretreatment seems to be protective of intestinal integrity, upon I/R injury, such an effect was not observable in the histopathological changes or plasma endotoxin level.
研究口服谷氨酰胺预处理是否能预防大鼠缺血再灌注(I/R)期间肠黏膜完整性的损害。
该研究分为两个系列,每个系列有40只大鼠。每个系列的动物分为四组。第一组作为对照组。第二组动物仅口服谷氨酰胺进行预处理,剂量为1 g/kg,持续4天。第三组给予正常饮食,并进行肠I/R,而第四组以同样方式口服谷氨酰胺进行预处理,然后进行肠I/R。在第一系列动物中,通过检测尿中(51)Cr标记的乙二胺四乙酸(EDTA)来测定肠黏膜通透性。在第二系列中,评估肠组织的组织病理学变化和血浆内毒素水平。
肠I/R导致肠通透性显著增加、血浆内毒素水平升高以及组织病理学改变恶化。肠I/R后,与给予正常饮食的大鼠相比,谷氨酰胺处理的大鼠通透性显著降低。然而,血浆内毒素水平或组织病理学结果未观察到显著变化。
尽管谷氨酰胺预处理似乎对肠完整性有保护作用,但在I/R损伤时,在组织病理学变化或血浆内毒素水平方面未观察到这种效果。